Natriumoxibat Reig Jofre (Sodium Oxybate)

Sodium oxybate, the active ingredient in Natriumoxibat Reig Jofre, is a gamma‑hydroxybutyrate (GHB) central nervous system depressant presented as an oral formulation for oral use. It is indicated for the treatment of narcolepsy with cataplexy and excessive daytime sleepiness in adult patients. GNH USA supplies Natriumoxibat Reig Jofre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Sodium oxybate acts on the sleep‑wake regulation pathway and is used for specific narcolepsy‑related conditions.

Narcolepsy with cataplexy: reduces the frequency and severity of cataplexy episodes. Excessive daytime sleepiness: improves wakefulness and reduces daytime sleepiness. Narcolepsy (overall): helps normalize sleep architecture and consolidates nighttime sleep.

Sodium oxybate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Vomiting: occasional emesis. - Insomnia: difficulty maintaining sleep. - Weight loss: reduced appetite or caloric intake.

Serious or Rare Side Effects: - Respiratory depression: reduced breathing effort, especially with other depressants. - Seizures: rare convulsive events. - Severe hypotension: marked drop in blood pressure. - Abuse potential: risk of dependence or misuse. - Allergic reactions: rash, itching, or anaphylaxis. - Coma: profound central nervous system depression.

When prescribing sodium oxybate, clinicians should consider several safety measures.

Assess sleep hygiene: ensure patients follow proper sleep‑schedule practices. Monitor respiratory function: watch for signs of depression, especially with other CNS depressants. Avoid concomitant CNS depressants: alcohol, opioids, benzodiazepines increase risk. Use with caution in hepatic impairment: liver dysfunction may alter drug clearance. Pregnancy and breastfeeding: safety not established; weigh risks versus benefits. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Sodium oxybate can interact with other medicines, altering its safety profile.

Major Interactions (Avoid): - Alcohol: additive CNS depression. - Opioids: heightened risk of respiratory depression. - Benzodiazepines: synergistic sedative effects. - Barbiturates: increased central nervous system depression. - Other GHB‑containing products: risk of overdose.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): may affect sleep architecture. - Antihistamines: can enhance sedation. - Anticonvulsants: potential alteration of seizure threshold. - Antihypertensives: possible additive hypotensive effect.